The Iron-Regulated Metastasis Suppressor NDRG1 Targets NEDD4L, PTEN, and SMAD4 and Inhibits the PI3K and Ras Signaling Pathways
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
AIMS: The metastasis suppressor gene, N-myc downstream regulated gene-1 (NDRG1), is negatively correlated with tumor progression in multiple neoplasms, including pancreatic cancer. Moreover, NDRG1 is an iron-regulated gene that is markedly upregulated by cellular iron-depletion using novel antitumor agents such as the chelator, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT), in pancreatic cancer cells. However, the exact function(s) of NDRG1 remain to be established and are important to elucidate. RESULTS: In the current study, using gene-array analysis along with NDRG1 overexpression and silencing, we identified the molecular targets of NDRG1 in three pancreatic cancer cell lines. We demonstrate that NDRG1 upregulates neural precursor cell expressed developmentally downregulated 4-like (NEDD4L) and GLI-similar-3 (GLIS3). Further studies examining the downstream effects of NEDD4L led to the discovery that NDRG1 affects the transforming growth factor-β (TGF-β) pathway, leading to the upregulation of two key tumor suppressor proteins, namely phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and mothers against decapentaplegic homolog-4 (SMAD4). Moreover, NDRG1 inhibited the phosphatidylinositol 3-kinase (PI3K) and Ras oncogenic pathways. INNOVATION: This study provides significant insights into the mechanisms underlying the antitumor activity of NDRG1. For the first time, a role for NDRG1 is established in regulating the key signaling pathways involved in oncogenesis (TGF-β, PI3K, and Ras pathways). CONCLUSION: The identified target genes of NDRG1 and their effect on the TGF-β signaling pathway reveal its molecular function in pancreatic cancer and a novel therapeutic avenue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526 · cited 1×
“Individual p-values were then adjusted using the Holm step-down procedure to reduce false positives (21).”
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556 · cited 4×
“This may reflect the low levels of TGF-b receptors (TGFbRI and TGFbRII) (37) in MIAPaCa-2 cells, which were significantly ( p < 0.”
InfluentialMaehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104 · cited 1×
“To further examine the downstream effects of increased PTEN in MIAPaCa-2 cells, we examined a key molecular target of PTEN, namely phosphorylated AKT (pAKT), which is reduced by this tumor suppressor (25, 35).”
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337 · cited 1×
“However, the tumor suppressor, SMAD4 (18, 19, 48), was significantly upregulated by NDRG1 in the nucleus of MIAPaCa-2 cells, independently of TGF-b1.”
PTEN and the PI3-Kinase Pathway in Cancer
Chalhoub, N., & Baker, S. J. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092311 · Cited by 1,245 · cited 5×
“Considering these latter data, it is notable that the phosphorylation of PI3K regulatory subunits (p85a/p85b/p55c) is crucial for pathway activation, as they serve to recruit catalytic subunits (p110a/b/d) to assemble the PI3K complex (5).”
InfluentialA mechanism of repression of TGFbeta / Smad signaling by oncogenic Ras
Kretzschmar, M., Doody, J., Timokhina, I., & Massague, J. (1999) · Genes & Development · doi:10.1101/gad.13.7.804 · Cited by 1,004 · cited 4×
“Moreover, Ras antagonizes SMADdependent TGF-b signaling by leading to the phosphorylation of SMAD2 at S245/250/255 (pSMAD2L) via pERK, inhibiting its nuclear translocation (11, 30).”
InfluentialCheng, J. Q., Ruggeri, B., Klein, W. M., Sonoda, G., Altomare, D. A., Watson, D. K., & Testa, J. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3636 · Cited by 793 · cited 1×
“This may be influenced by the fact that PANC-1 cells have mutated pAKT (7) and may respond differently to NDRG1.”
Chapter 2 PI3K/PTEN Signaling in Angiogenesis and Tumorigenesis
(2009) · Advances in Cancer Research · doi:10.1016/s0065-230x(09)02002-8 · Cited by 620 · cited 8×
“In fact, a negative feedback-loop exists between PTEN and the PI3K pathway (5, 9, 20, 25).”
InfluentialThe Nedd4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture
Ingham, R. J., Gish, G., & Pawson, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207436 · Cited by 531 · cited 1×
“interest, as it negatively regulates the TGF-b pathway by promoting the turnover of TGFbRI and pSMAD2/3 (6, 15, 23, 24).”
Whitnall, M., Howard, J., Ponka, P., & Richardson, D. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604979103 · Cited by 509 · cited 12×
“NDRG1 expression is induced by cellular iron depletion (12, 33, 47).”
InfluentialSelf-citationGeissmann (1998) · doi:10.1084/jem.187.6.961 · Cited by 501
Ubiquitin Ligase Nedd4L Targets Activated Smad2/3 to Limit TGF-β Signaling
Gao, S., Alarcón, C., Sapkota, G., Rahman, S., Chen, P.-Y., Goerner, N., Macias, M. J., Erdjument-Bromage, H., Tempst, P., & Massagué, J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.043 · Cited by 389
Levy, L., & Hill, C. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8108-8125.2005 · Cited by 342
MURRAY, J. T., CAMPBELL, D. G., MORRICE, N., AULD, G. C., SHPIRO, N., MARQUEZ, R., PEGGIE, M., BAIN, J., BLOOMBERG, G. B., GRAHAMMER, F., et al. (2004) · Biochemical Journal · doi:10.1042/bj20041057 · Cited by 341 · cited 1×
“As previously found (27), two NDRG1 bands at 43- and 44kDa were detected and may correspond to its different phosphorylation states (39).”
Le, N. T. V., & Richardson, D. R. (2004) · Blood · doi:10.1182/blood-2004-05-1866 · Cited by 321 · cited 17×
“Western analysis was performed (33) using antibodies outlined in Supplementary Data.”
InfluentialSelf-citationThe Drg-1 gene suppresses tumor metastasis in prostate cancer.
Bandyopadhyay, S., Pai, S. K., Gross, S. C., Hirota, S., Hosobe, S., Miura, K., Saito, K., Commes, T., Hayashi, S., Watabe, M., et al. (2003) · PubMed · Cited by 308
Homozygous deletion map at 18q21.1 in pancreatic cancer.
Hahn, S. A., Hoque, A. T., Moskaluk, C. A., da Costa, L. T., Schutte, M. E. M., Rozenblum, E., Seymour, A. B., Weinstein, C. L., Yeo, C. J., Hruban, R. H., et al. (1996) · PubMed · Cited by 265
Tuning Cell Cycle Regulation with an Iron Key
Yu, Y., Kovacevic, Z., & Richardson, D. R. (2007) · Cell Cycle · doi:10.4161/cc.6.16.4603 · Cited by 232 · cited 1×
“) that are modulated in response to chelators (50).”
Self-citationEllen, T. P., Ke, Q., Zhang, P., & Costa, M. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm200 · Cited by 220 · cited 1×
“NDRG1 has been negatively correlated with metastasis in a number of neoplasms, including PCa (2, 3, 13, 28, 36).”
Expression of NDRG1, a differentiation-related gene, in human tissues
Lachat, P., Shaw, P., Gebhard, S., van Belzen, N., Chaubert, P., & Bosman, F. T. (2002) · Histochemistry and Cell Biology · doi:10.1007/s00418-002-0460-9 · Cited by 196 · cited 1×
“Notably, NDRG1 was primarily localized in the cytoplasm, as previously described (31).”
Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression
Bandyopadhyay, S., Pai, S. K., Hirota, S., Hosobe, S., Takano, Y., Saito, K., Piquemal, D., Commes, T., Watabe, M., Gross, S. C., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207734 · Cited by 194 · cited 1×
“NDRG1 has been negatively correlated with metastasis in a number of neoplasms, including PCa (2, 3, 13, 28, 36).”
Kovacevic, Z., Chikhani, S., Lovejoy, D. B., & Richardson, D. R. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073627 · Cited by 177
Self-citationSmad4-mediated TGF-β signaling in tumorigenesis
Yang, G., & Yang, X. Y. (2010) · International Journal of Biological Sciences · doi:10.7150/ijbs.6.1 · Cited by 162
Maruyama, Y., Ono, M., Kawahara, A., Yokoyama, T., Basaki, Y., Kage, M., Aoyagi, S., Kinoshita, H., & Kuwano, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0183 · Cited by 160 · cited 5×
“Moreover, NDRG1 is positively correlated with an increased differentiation of PCa (1), as well as pathological stage, histological grading, and reduced invasion (36).”
InfluentialKim, Y. S., Nakanishi, G., Lewandoski, M., & Jetten, A. M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg776 · Cited by 149
Akt as a therapeutic target in cancer
Steelman, L. S., Stadelman, K. M., Chappell, W. H., Horn, S., Bäsecke, J., Cervello, M., Nicoletti, F., Libra, M., Stivala, F., Martelli, A. M., et al. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.9.1139 · Cited by 140 · cited 1×
“Further investigations demonstrated that phosphorylated mTOR (pmTOR), a downstream target of pAKT that functions in promoting proliferation (43), was also significantly ( p < 0.”
Subramanian, G., Schwarz, R. E., Higgins, L., McEnroe, G., Chakravarty, S., Dugar, S., & Reiss, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0018 · Cited by 138 · cited 1×
“001) lower than in TGF-b-sensitive PANC-1 cells (44) (Supplementary Fig.”
Homo-oligomerisation and nuclear localisation of mouse histone deacetylase 111Edited by J. Karn
Taplick, J., Kurtev, V., Kroboth, K., Posch, M., Lechner, T., & Seiser, C. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4569 · Cited by 126 · cited 1×
“1D), which was localized in the nucleus (45).”
RAS/ERK modulates TGF -regulated PTEN expression in human pancreatic adenocarcinoma cells
Chow, J. Y. C., Quach, K. T., Cabrera, B. L., Cabral, J. A., Beck, S. E., & Carethers, J. M. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm159 · Cited by 115
Kovačević, Ž., Sivagurunathan, S., Mangs, H., Chikhani, S., Zhang, D., & Richardson, D. R. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr046 · Cited by 99 · cited 1×
“Interestingly, we have previously demonstrated that NDRG1 also promotes p21 transcription in cancer cells (29), which is consistent with its positive effect on SMAD4 expression.”
Self-citationHosoi, F., Izumi, H., Kawahara, A., Murakami, Y., Kinoshita, H., Kage, M., Nishio, K., Kohno, K., Kuwano, M., & Ono, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4882 · Cited by 94
Burris, H. A., & Rocha‐Lima, C. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0134 · Cited by 82 · cited 1×
“A new approach to PCa treatment has focused on moleculartargeted therapies, with studies showing promising benefits (4).”
Murakami, Y., Hosoi, F., Izumi, H., Maruyama, Y., Ureshino, H., Watari, K., Kohno, K., Kuwano, M., & Ono, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.100 · Cited by 78 · cited 1×
“Significantly, the top band is crucial for the antitumor function of NDRG1 in PCa (38).”
Chow, J. Y. C., Dong, H., Quach, K. T., Nguyen, P. N. V., Chen, K., & Carethers, J. M. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00411.2007 · Cited by 76
Gysin, S., Rickert, P., Kastury, K., & McMahon, M. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20216 · Cited by 73 · cited 1×
“Moreover, while MIAPaCa-2 and PANC-1 cells have no mutations in SMAD4, CFPAC-1 cells have a homozygous deletion of this latter protein (17), which could have an impact on how these cells respond to TGF-b and NDRG1.”
Laghi, L., Orbetegli, O., Bianchi, P. P., Zerbi, A., Carlo, V. D., Boland, C. R., & Malesci, A. (2002) · Oncogene · doi:10.1038/sj.onc.1205533 · Cited by 71 · cited 1×
“SMAD4 inhibits Ras signaling in PCa (9, 34), and constitutively activated Ras (32) contributes to PCa progression and is a mediator of PTEN suppression (11).”
Angst, E., Sibold, S., Tiffon, C., Weimann, R., Gloor, B., Candinas, D., & Stroka, D. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603256 · Cited by 66 · cited 1×
“Moreover, NDRG1 is positively correlated with an increased differentiation of PCa (1), as well as pathological stage, histological grading, and reduced invasion (36).”
Nedd4L expression is downregulated in prostate cancer compared to benign prostatic hyperplasia
Hu, X., Xu, Y. M., Fu, Q., Yu, J., & Huang, J. (2008) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2008.09.015 · Cited by 63 · cited 1×
“interest, as it negatively regulates the TGF-b pathway by promoting the turnover of TGFbRI and pSMAD2/3 (6, 15, 23, 24).”
TGFbeta regulated gene expression by Smads and Sp1/KLF-like transcription factors in cancer.
Ellenrieder, V. (2008) · PubMed · Cited by 61
TGF-β downregulates PTEN via activation of NF-κB in pancreatic cancer cells
Chow, J. Y. C., Ban, M., Wu, H. L., Nguyen, F., Huang, M. J., Chung, H., Dong, H., & Carethers, J. M. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00344.2009 · Cited by 61
Venkatasubbarao, K., Ahmed, M. M., Mohiuddin, M., Swiderski, C. F., Lee, E., Gower, W. R., Salhab, K. F., McGrath, P. C., Strodel, W. E., & Freeman, J. W. (2000) · PubMed · Cited by 45
Disruption of TGFβ Signaling Pathways in Human Pancreatic Cancer Cells
Simeone, D. M., Pham, T. M., & Logsdon, C. D. (2000) · Annals of Surgery · doi:10.1097/00000658-200007000-00011 · Cited by 39
Chow, J. Y. C., Cabral, J., Chang, J. K., & Carethers, J. M. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.10.6665 · Cited by 38
Post‐transcriptional and post‐translational regulation of PTEN by transforming growth factor‐β1
Yang, Y., Zhou, F., Fang, Z., Wang, L., Li, Z., Sun, L., Wang, C., Yao, W., Cai, X., Jin, J., et al. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22100 · Cited by 35
He, J., de la Monte, S. M., & Wands, J. R. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.146 · Cited by 26
Present treatment and future expectations in advanced pancreatic cancer.
Stathopoulos, G. P., Androulakis, N., Souglakos, J., Stathopoulos, J., & Georgoulias, V. (2008) · PubMed · Cited by 20
Cited by
NEDD4-2 (NEDD4L): The ubiquitin ligase for multiple membrane proteins
Goel, P., Manning, J. A., & Kumar, S. (2015) · Gene · doi:10.1016/j.gene.2014.11.051 · Cited by 167
“Hepatocellular carcinoma caused by altered Wnt/βcatenin signaling in human hepatoma cells show an apparent increase in levels of NEDD4L (Kovacevic et al., 2013).”
Background
Metadata
- Authors
- Kovacevic, Z., Chikhani, S., Lui, G. Y. L., Sivagurunathan, S., & Richardson, D. R.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2013-03-10
- Volume
- 18
- Issue
- 8
- Pages
- 874-887
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2086605620
- Cited by
- 168
- References
- 46
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.